Reaction Details Report a problem with these data
Target
Mitogen-activated protein kinase 1
Ligand
BDBM365208
Substrate
n/a
Meas. Tech.
Enzymatic Assay
IC50
0.103±n/a nM
Citation
 Kolesnikov, A; Do, S Serine/threonine kinase inhibitors US Patent  US10842799 Publication Date 11/24/2020 
Target
Name:
Mitogen-activated protein kinase 1
Synonyms:
ERK2 | ERT1 | Extracellular signal-regulated kinase 2 | Extracellular signal-regulated kinase 2 (ERK-2) | Extracellular signal-regulated kinase 2 (ERK2) | MAP Kinase 2/ERK2 | MAPK 2 | MAPK1 | MK01_HUMAN | Mitogen activated kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK-2) | Mitogen-activated protein kinase 1 (ERK2) | Mitogen-activated protein kinase 2 | PRKM1 | PRKM2 | p42-MAPK
Type:
Ser/Thr Protein Kinase
Mol. Mass.:
41392.76
Organism:
Homo sapiens (Human)
Description:
P28482
Residue:
360
Sequence:
MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS
  
Inhibitor
Name:
BDBM365208
Synonyms:
N-(1-methyl-1H-pyrazol-5- yl)-4-(9-((4-methylthiazol-2- yl)methyl)-8,9-dihydro-7H-6- oxa-1,2,2a1- triazabenzo[cd]azulen-4- yl)pyrimidin-2-amine | US10517878, Compound I-109 | US10842799, I-109 | US11376260, Example I-109S | US9867833, Compound I-109(S)
Type:
Small organic molecule
Emp. Form.:
C22H21N9OS
Mol. Mass.:
459.527
SMILES:
Cc1csc(CC2CCOc3cc(cc4nnc2n34)-c2ccnc(Nc3ccnn3C)n2)n1
Structure:
Search PDB for entries with ligand similarity: